Evaluation of the Safety, Effectiveness, and Clinical Impact of the Terry2™ Dual Artery Hemostasis Device in Patients Undergoing Trans-radial or Trans-cubital Catheterization

What this Trial Is About

This research aims to evaluate the use of the Terry2™ band, a new dual artery hemostasis device, in patients undergoing diagnostic or interventional catheterization through radial or cubital artery access. Radial Artery Occlusion (RAO) is a common complication after trans-radial catheterization, which can limit future artery access or graft use. Current non-occlusive hemostasis methods reduce RAO risk but are time-consuming and require repeated nursing interventions, limiting their use. The study involves applying the Terry2™ band at the end of the catheterization procedure. This device compresses both the radial and cubital arteries simultaneously to achieve non-occlusive hemostasis more efficiently, aiming to speed up hemostasis, reduce nursing workload, and increase patient comfort. Staff will be trained via an educational video on how to use the device, and its application will be checked for effectiveness before the patient returns to their room. Participants will be monitored for the rate of RAO and other access site complications up to 30 days after catheterization. Researchers will also measure total time to hemostasis, patient comfort during the procedure, and nursing time involved up to 24 hours post-procedure. Radial artery patency will be checked by pulse oximetry and, if needed, confirmed by ultrasound Doppler. The total participation duration varies with the follow-up period extending up to one month.

Radial Artery Occlusion and Dual Artery Hemostasis After Transradial Approach.